MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.bja.2020.11.038

Медицинская библиотека · British journal of anaesthesia · 2021

Population pharmacokinetics of ropivacaine used for local infiltration anaesthesia during primary total unilateral and simultaneous bilateral knee arthroplasty.

Gromov Kirill, Grassin-Delyle Stanislas, Foss Nicolai B, Pedersen Lars Møller, Nielsen Christian S, Lamy Elodie, Troelsen Anders, Urien Saik, Husted Henrik

Клиническое исследованиеСтатьяПеревод в очереди

Аннотация

BACKGROUND

Ropivacaine is commonly used in local infiltration anaesthesia (LIA) as pain management after total knee arthroplasty (TKA). Although considered safe, no studies evaluated the pharmacokinetics of high-dose ropivacaine infiltration in simultaneous bilateral TKA.

METHODS

We studied 13 patients undergoing unilateral and 15 undergoing bilateral TKA. Standard LIA technique was used with ropivacaine 0.2%, 200 ml (400 mg) injected peri-articularly in each knee. Free and total plasma concentrations of ropivacaine were measured within 24 h using liquid chromatography-mass spectrometry. A population pharmacokinetic model was built using non-linear mixed-effects models.

RESULTS

Peak free ropivacaine concentration was 0.030 (0.017-0.071) μg ml-1 (mean [99% confidence interval]) vs 0.095 (0.047-0.208) μg ml-1, and peak total ropivacaine concentration was 0.756 (0.065-1.222) μg ml-1vs 1.695 (0.077-3.005) μg ml-1 for unilateral and bilateral TKA, respectively. The pharmacokinetics was ascribed a one-compartment model with first-order absorption. The main identified covariates were protein binding, allometrically scaled body weight on clearance and volume, and unilateral or bilateral surgery on volume.

CONCLUSIONS

This is the first study to investigate the pharmacokinetics of free and total ropivacaine after unilateral and bilateral TKA. A population model was successfully built and peak free ropivacaine concentration stayed below previously proposed toxic thresholds in patients undergoing unilateral and bilateral TKA receiving LIA with high-dose ropivacaine.

CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04702282.

Для цитирования: Gromov Kirill, Grassin-Delyle Stanislas, Foss Nicolai B, Pedersen Lars Møller, Nielsen Christian S, Lamy Elodie, Troelsen Anders, Urien Saik, Husted Henrik. Population pharmacokinetics of ropivacaine used for local infiltration anaesthesia during primary total unilateral and simultaneous bilateral knee arthroplasty.. British journal of anaesthesia. 2021. DOI: 10.1016/j.bja.2020.11.038.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.